Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Holroyd

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Menopause International|September 10, 2011
Vitamin D and the postmenopausal populationChristopher R Holroyd, Cyrus Cooper, Nicholas C Harvey
Autoimmunity Reviews|March 13, 2016
Are there dangers in biologic dose reduction strategies?Christopher K Y Chan, Christopher R Holroyd, Alice Mason, et al.
BMC Musculoskeletal Disorders|April 8, 2020
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?Tom Nadin, Dinny Wallis, Christopher R Holroyd, et al.
The Journal of Clinical Endocrinology and Metabolism|March 21, 2023
Parent-Offspring Associations in Body Composition: Findings From the Southampton Women's Survey Prospective Cohort StudyRebecca J Moon, Stefania D'Angelo, Christopher R Holroyd, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 22, 2016
Placental Size Is Associated Differentially With Postnatal Bone Size and DensityChristopher R Holroyd, Clive Osmond, David Jp Barker, et al.
Clinical and Experimental Rheumatology|January 22, 2018
Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritisChristopher R Holroyd, Lucy Parker, Sarah Bennett, et al.
Arthritis Care & Research|January 22, 2015
Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy?Jonathan L Marks, Christopher R Holroyd, Borislav D Dimitrov, et al.
Rheumatology (Oxford, England)|August 24, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritisChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Rheumatology (Oxford, England)|September 22, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritisChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Rheumatology (Oxford, England)|August 24, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summaryChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Menopause International|September 10, 2011
Vitamin D and the postmenopausal populationChristopher R Holroyd, Cyrus Cooper, Nicholas C Harvey
Autoimmunity Reviews|March 13, 2016
Are there dangers in biologic dose reduction strategies?Christopher K Y Chan, Christopher R Holroyd, Alice Mason, et al.
BMC Musculoskeletal Disorders|April 8, 2020
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?Tom Nadin, Dinny Wallis, Christopher R Holroyd, et al.
The Journal of Clinical Endocrinology and Metabolism|March 21, 2023
Parent-Offspring Associations in Body Composition: Findings From the Southampton Women's Survey Prospective Cohort StudyRebecca J Moon, Stefania D'Angelo, Christopher R Holroyd, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 22, 2016
Placental Size Is Associated Differentially With Postnatal Bone Size and DensityChristopher R Holroyd, Clive Osmond, David Jp Barker, et al.
Clinical and Experimental Rheumatology|January 22, 2018
Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritisChristopher R Holroyd, Lucy Parker, Sarah Bennett, et al.
Arthritis Care & Research|January 22, 2015
Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy?Jonathan L Marks, Christopher R Holroyd, Borislav D Dimitrov, et al.
Rheumatology (Oxford, England)|August 24, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritisChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Rheumatology (Oxford, England)|September 22, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritisChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Rheumatology (Oxford, England)|August 24, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summaryChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Pageof 1